| PERIOD ENDING | 30-Sep-09 | 3-Apr-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,647 | 34,718 | 34,718 | 11,020 | | Cost of Revenue | 7,166 | 20,550 | 20,550 | 6,678 | | | Gross Profit | 5,481 | 14,168 | 14,168 | 4,343 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,653 | 14,181 | 14,181 | 4,877 | | Non Recurring | 473 | 1,167 | 1,167 |
-
| | Others |
-
|
-
|
-
| 308 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 356 | (1,180) | (1,180) | (843) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82 | 234 | 234 | 69 | | Earnings Before Interest And Taxes | 438 | (946) | (946) | (774) | | Interest Expense | 81 | 347 | 347 | 96 | | Income Before Tax | 357 | (1,293) | (1,293) | (870) | | Income Tax Expense | 133 | (501) | (501) | (467) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 224 | (791) | (791) | (404) | | | Non-recurring Events | | Discontinued Operations |
-
| (1,409) | (1,409) | (1,312) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 224 | (2,200) | (2,200) | (1,716) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $224 | ($2,200) | ($2,200) | ($1,716) |
|
0.51% Nasdaq 
Income Statement
